- Published on
Ophthalmology – Convergence Insufficiency
Convergence insufficiency is a common binocular vision disorder in which the eyes are unable to converge effectively for near tasks or cannot maintain convergence once achieved. This leads to difficulty sustaining proper alignment when focusing on objects up close, such as during reading or screen use. It is relatively common, with reported prevalence ranging widely from 1% to 25% of the population.
The underlying problem is a deficiency in fusional convergence, often resulting in an exophoria or intermittent exotropia at near. Patients must exert excessive effort to maintain single binocular vision, which leads to symptoms. The condition is largely considered innervational (neurologic control issue) rather than structural, supported by its strong response to therapy.
Patients typically present with symptoms related to prolonged near work. These include headaches (often frontal or periocular), eye strain (asthenopia), blurred or moving text, difficulty concentrating, and loss of place while reading. Some experience diplopia at near, which may lead them to close one eye to read. Symptoms often worsen with fatigue, illness, or stress, and some individuals avoid near tasks altogether to reduce discomfort.
On examination, key findings include a receded near point of convergence (NPC)—normally within about 4 cm in children—and reduced fusional convergence amplitudes. Eye movements during convergence may appear slow, jerky, or poorly sustained. Cover testing at near often reveals an exodeviation, though some patients may have minimal or no deviation. Reduced stereoacuity may also be present.
Diagnosis is clinical, and imaging is generally not required unless there are neurologic red flags or failure to improve with therapy. Differential diagnoses include accommodative insufficiency, uncorrected refractive errors (especially hyperopia), convergence paralysis, and neurologic causes such as midbrain lesions or head trauma.
The mainstay of treatment is orthoptic (vision) therapy, which has strong evidence supporting its effectiveness. This includes vergence and accommodative exercises using prisms, lenses, stereograms, or computer-based programs. A commonly used home exercise is pencil push-ups, where the patient focuses on a near target as it is slowly brought closer while maintaining single vision.
For symptomatic relief, especially in adults, base-in prism reading glasses may be helpful. Other options such as bifocals or over-minus lenses can be used selectively but may not be suitable for all patients. Surgery (e.g., medial rectus resection) is rarely needed and reserved for severe, refractory cases.
The prognosis is excellent, with most patients experiencing significant improvement or resolution of symptoms with appropriate therapy. However, symptoms can recur over time, especially with increased visual demands, and patients may require periodic re-treatment.
Convergence insufficiency is a common binocular vision disorder in which the eyes are unable to converge effectively for near tasks or cannot maintain convergence once achieved. This leads to difficulty sustaining proper alignment when focusing on objects up close, such as during reading or screen use. It is relatively common, with reported prevalence ranging widely from 1% to 25% of the population.
The underlying problem is a deficiency in fusional convergence, often resulting in an exophoria or intermittent exotropia at near. Patients must exert excessive effort to maintain single binocular vision, which leads to symptoms. The condition is largely considered innervational (neurologic control issue) rather than structural, supported by its strong response to therapy.
Patients typically present with symptoms related to prolonged near work. These include headaches (often frontal or periocular), eye strain (asthenopia), blurred or moving text, difficulty concentrating, and loss of place while reading. Some experience diplopia at near, which may lead them to close one eye to read. Symptoms often worsen with fatigue, illness, or stress, and some individuals avoid near tasks altogether to reduce discomfort.
On examination, key findings include a receded near point of convergence (NPC)—normally within about 4 cm in children—and reduced fusional convergence amplitudes. Eye movements during convergence may appear slow, jerky, or poorly sustained. Cover testing at near often reveals an exodeviation, though some patients may have minimal or no deviation. Reduced stereoacuity may also be present.
Diagnosis is clinical, and imaging is generally not required unless there are neurologic red flags or failure to improve with therapy. Differential diagnoses include accommodative insufficiency, uncorrected refractive errors (especially hyperopia), convergence paralysis, and neurologic causes such as midbrain lesions or head trauma.
The mainstay of treatment is orthoptic (vision) therapy, which has strong evidence supporting its effectiveness. This includes vergence and accommodative exercises using prisms, lenses, stereograms, or computer-based programs. A commonly used home exercise is pencil push-ups, where the patient focuses on a near target as it is slowly brought closer while maintaining single vision.
For symptomatic relief, especially in adults, base-in prism reading glasses may be helpful. Other options such as bifocals or over-minus lenses can be used selectively but may not be suitable for all patients. Surgery (e.g., medial rectus resection) is rarely needed and reserved for severe, refractory cases.
The prognosis is excellent, with most patients experiencing significant improvement or resolution of symptoms with appropriate therapy. However, symptoms can recur over time, especially with increased visual demands, and patients may require periodic re-treatment.
- Published on
Ophthalmology – Cotton Wool Spots
Cotton wool spots are small, superficial white lesions of the retina, typically less than half the size of the optic disc. They represent localized areas of retinal ischemia and are most important clinically as a sign of underlying systemic disease, rather than a primary ocular disorder.
These lesions occur due to occlusion of precapillary arterioles, leading to interruption of axoplasmic flow within the retinal nerve fiber layer. This results in accumulation of intracellular debris (cytoid bodies), which gives the characteristic fluffy white appearance seen on fundoscopic examination.
Patients with cotton wool spots are usually asymptomatic, unless the lesion is located near the macula or is associated with other retinal pathology such as macular edema or hemorrhage, in which case vision may be affected. On examination, they appear as discrete, soft, white patches on the retina and are often accompanied by other signs of retinal vascular disease, including hemorrhages, exudates, edema, or neovascularization.
The most common associated systemic conditions are diabetes mellitus, systemic hypertension, and atherosclerotic vascular disease. However, cotton wool spots can also be seen in a wide range of other conditions, including collagen vascular diseases (e.g., lupus), infections (e.g., HIV), hematologic disorders (e.g., leukemia, severe anemia), cardiac conditions (e.g., endocarditis), and trauma (e.g., Purtscher retinopathy). Because of this broad differential, their presence should prompt a systemic evaluation.
Initial workup typically includes blood glucose, HbA1c, lipid profile, complete blood count, inflammatory markers (ESR, CRP), and additional tests guided by clinical suspicion. Fluorescein angiography can confirm areas of capillary nonperfusion and help identify associated retinal vascular disease. In selected cases, further investigations such as cardiac evaluation, carotid imaging, or temporal artery biopsy may be necessary.
There is no direct treatment for cotton wool spots themselves. Management focuses on identifying and treating the underlying systemic condition. Follow-up examination in 1–2 months is recommended to ensure resolution and to monitor for progression or additional retinal findings.
The visual prognosis is generally good, as cotton wool spots often resolve spontaneously. However, the overall prognosis depends on the severity and control of the underlying systemic disease, which can have significant implications for long-term health.
Cotton wool spots are small, superficial white lesions of the retina, typically less than half the size of the optic disc. They represent localized areas of retinal ischemia and are most important clinically as a sign of underlying systemic disease, rather than a primary ocular disorder.
These lesions occur due to occlusion of precapillary arterioles, leading to interruption of axoplasmic flow within the retinal nerve fiber layer. This results in accumulation of intracellular debris (cytoid bodies), which gives the characteristic fluffy white appearance seen on fundoscopic examination.
Patients with cotton wool spots are usually asymptomatic, unless the lesion is located near the macula or is associated with other retinal pathology such as macular edema or hemorrhage, in which case vision may be affected. On examination, they appear as discrete, soft, white patches on the retina and are often accompanied by other signs of retinal vascular disease, including hemorrhages, exudates, edema, or neovascularization.
The most common associated systemic conditions are diabetes mellitus, systemic hypertension, and atherosclerotic vascular disease. However, cotton wool spots can also be seen in a wide range of other conditions, including collagen vascular diseases (e.g., lupus), infections (e.g., HIV), hematologic disorders (e.g., leukemia, severe anemia), cardiac conditions (e.g., endocarditis), and trauma (e.g., Purtscher retinopathy). Because of this broad differential, their presence should prompt a systemic evaluation.
Initial workup typically includes blood glucose, HbA1c, lipid profile, complete blood count, inflammatory markers (ESR, CRP), and additional tests guided by clinical suspicion. Fluorescein angiography can confirm areas of capillary nonperfusion and help identify associated retinal vascular disease. In selected cases, further investigations such as cardiac evaluation, carotid imaging, or temporal artery biopsy may be necessary.
There is no direct treatment for cotton wool spots themselves. Management focuses on identifying and treating the underlying systemic condition. Follow-up examination in 1–2 months is recommended to ensure resolution and to monitor for progression or additional retinal findings.
The visual prognosis is generally good, as cotton wool spots often resolve spontaneously. However, the overall prognosis depends on the severity and control of the underlying systemic disease, which can have significant implications for long-term health.
- Published on
Ophthalmology – Dacryocystitis
Dacryocystitis is an inflammatory condition of the lacrimal sac, most commonly caused by infection and usually occurring as a result of nasolacrimal duct obstruction (NLDO). It may present in acute, chronic, or congenital forms and often leads to recurrent episodes if the underlying obstruction is not addressed. Structural predispositions such as a brachycephalic head shape or a narrow face with a flat nasal bridge may increase susceptibility, although no preventive measures exist prior to the first episode.
The pathophysiology involves stagnation of tears within the lacrimal sac due to obstruction. Normally, the lacrimal drainage system is colonized with bacteria, but continuous tear flow prevents infection. When this flow is blocked, bacteria proliferate, leading to inflammation and infection of the lacrimal sac. Common causative organisms include Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus species, Pneumococcus, as well as gram-negative organisms and anaerobes. Causes of obstruction may include structural abnormalities, nasal inflammation, trauma (such as nasal fractures), punctal plugs, tumors, or cysts.
Clinically, patients typically present with pain, redness, and swelling over the medial canthal region, often accompanied by epiphora (excess tearing). On examination, there is tenderness over the lacrimal sac, a firm swelling below the medial canthus, and purulent discharge from the puncta, especially when pressure is applied. In chronic cases, a dacryocutaneous fistula may develop with spontaneous drainage. Severe or untreated cases can progress to orbital cellulitis, which may present with decreased vision, afferent pupillary defect, and restricted eye movements.
Diagnosis is primarily clinical, based on characteristic history and examination findings. In atypical or refractory cases, further evaluation may be required. Laboratory tests such as CBC or inflammatory markers may be considered if systemic or inflammatory causes are suspected. Cultures of discharge can help guide antibiotic therapy in resistant cases. Imaging, such as CT scanning, may be used to assess structural abnormalities or complications. Additional diagnostic tools like dacryocystography, dacryoscintigraphy, or nasal endoscopy may be used to evaluate the anatomy of the lacrimal drainage system.
Management initially focuses on treating the infection. This includes oral antibiotics, warm compresses, and topical antibiotic drops or ointments. In more severe cases or when there is concern for orbital cellulitis, intravenous antibiotics are required. However, definitive treatment involves addressing the underlying obstruction. Once the acute infection has resolved, a dacryocystorhinostomy (DCR) is typically performed to create a new drainage pathway between the lacrimal sac and the nasal cavity, thereby preventing recurrence. Both external and endonasal approaches are effective, with similar success rates.
The prognosis for dacryocystitis is generally excellent with appropriate treatment, particularly when the underlying obstruction is corrected. However, complications can occur if the condition is not managed promptly. These include orbital cellulitis, which can threaten vision, and in rare severe cases, progression to sepsis and even death. Early recognition and treatment are therefore essential to prevent serious outcomes.
Dacryocystitis is an inflammatory condition of the lacrimal sac, most commonly caused by infection and usually occurring as a result of nasolacrimal duct obstruction (NLDO). It may present in acute, chronic, or congenital forms and often leads to recurrent episodes if the underlying obstruction is not addressed. Structural predispositions such as a brachycephalic head shape or a narrow face with a flat nasal bridge may increase susceptibility, although no preventive measures exist prior to the first episode.
The pathophysiology involves stagnation of tears within the lacrimal sac due to obstruction. Normally, the lacrimal drainage system is colonized with bacteria, but continuous tear flow prevents infection. When this flow is blocked, bacteria proliferate, leading to inflammation and infection of the lacrimal sac. Common causative organisms include Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus species, Pneumococcus, as well as gram-negative organisms and anaerobes. Causes of obstruction may include structural abnormalities, nasal inflammation, trauma (such as nasal fractures), punctal plugs, tumors, or cysts.
Clinically, patients typically present with pain, redness, and swelling over the medial canthal region, often accompanied by epiphora (excess tearing). On examination, there is tenderness over the lacrimal sac, a firm swelling below the medial canthus, and purulent discharge from the puncta, especially when pressure is applied. In chronic cases, a dacryocutaneous fistula may develop with spontaneous drainage. Severe or untreated cases can progress to orbital cellulitis, which may present with decreased vision, afferent pupillary defect, and restricted eye movements.
Diagnosis is primarily clinical, based on characteristic history and examination findings. In atypical or refractory cases, further evaluation may be required. Laboratory tests such as CBC or inflammatory markers may be considered if systemic or inflammatory causes are suspected. Cultures of discharge can help guide antibiotic therapy in resistant cases. Imaging, such as CT scanning, may be used to assess structural abnormalities or complications. Additional diagnostic tools like dacryocystography, dacryoscintigraphy, or nasal endoscopy may be used to evaluate the anatomy of the lacrimal drainage system.
Management initially focuses on treating the infection. This includes oral antibiotics, warm compresses, and topical antibiotic drops or ointments. In more severe cases or when there is concern for orbital cellulitis, intravenous antibiotics are required. However, definitive treatment involves addressing the underlying obstruction. Once the acute infection has resolved, a dacryocystorhinostomy (DCR) is typically performed to create a new drainage pathway between the lacrimal sac and the nasal cavity, thereby preventing recurrence. Both external and endonasal approaches are effective, with similar success rates.
The prognosis for dacryocystitis is generally excellent with appropriate treatment, particularly when the underlying obstruction is corrected. However, complications can occur if the condition is not managed promptly. These include orbital cellulitis, which can threaten vision, and in rare severe cases, progression to sepsis and even death. Early recognition and treatment are therefore essential to prevent serious outcomes.
- Published on
Ophthalmology – Dacryocele
A dacryocele is a distension of the lacrimal sac that typically presents in newborns or early infancy due to congenital obstruction of the nasolacrimal drainage system. It is also referred to as dacryocystocele or lacrimal sac mucocele. Although uncommon, it is an important condition because it can lead to infection or airway compromise. Most cases are sporadic, though rare familial occurrences have been described.
The underlying mechanism involves a dual obstruction of the lacrimal drainage pathway. There is distal blockage at the valve of Hasner combined with proximal functional obstruction at the valve of Rosenmüller. This prevents both forward and backward flow of tears and secretions, leading to accumulation within the lacrimal sac and progressive cystic enlargement. In some infants, an associated intranasal cyst may develop, further worsening obstruction and potentially causing nasal airway compromise.
Clinically, dacryocele presents as a firm, bluish swelling below the medial canthus in a neonate. The mass is typically non-mobile and may cause upward displacement of the lower eyelid. It may occur on one or both sides. In uncomplicated cases, it is painless, but secondary infection can lead to redness, tenderness, and swelling, indicating dacryocystitis or preseptal cellulitis. In severe cases, particularly when an intranasal cyst is present, the infant may develop respiratory distress, as newborns are obligate nasal breathers. Feeding difficulties may also be observed.
Diagnosis is primarily clinical, based on the characteristic appearance. Gentle pressure over the swelling may produce mucoid discharge from the puncta or into the nasal cavity, which supports the diagnosis. If infection is suspected, laboratory investigations such as complete blood count and cultures may be necessary. Imaging studies like CT or MRI are reserved for cases with suspected nasal obstruction or to evaluate for an intranasal cyst, and ENT consultation may be required.
The differential diagnosis includes other medial canthal masses such as capillary hemangioma, dermoid cyst, and encephalocele. These can usually be distinguished based on their clinical features, including color, consistency, mobility, and location.
Initial management often involves conservative treatment with gentle digital massage, which may decompress the cyst. If infection is present, systemic antibiotics are required due to the risk of serious complications. However, many cases, especially those with infection or airway compromise, require surgical intervention. The definitive treatment is probing and irrigation of the nasolacrimal duct, often performed under general anesthesia. Nasal endoscopy may be used to identify and treat associated intranasal cysts, improving success rates.
The prognosis is excellent, with approximately 99% resolution following appropriate surgical management, particularly when nasal endoscopy is utilized. Nevertheless, some infants may later develop typical nasolacrimal duct obstruction.
Complications, although uncommon, include recurrent obstruction, fistula formation if improperly drained externally, and infections such as dacryocystitis, preseptal cellulitis, or even sepsis and meningitis. Parents should be educated on proper massage techniques and advised to watch for warning signs such as redness, swelling, fever, or breathing and feeding difficulties, which require urgent medical evaluation.
A dacryocele is a distension of the lacrimal sac that typically presents in newborns or early infancy due to congenital obstruction of the nasolacrimal drainage system. It is also referred to as dacryocystocele or lacrimal sac mucocele. Although uncommon, it is an important condition because it can lead to infection or airway compromise. Most cases are sporadic, though rare familial occurrences have been described.
The underlying mechanism involves a dual obstruction of the lacrimal drainage pathway. There is distal blockage at the valve of Hasner combined with proximal functional obstruction at the valve of Rosenmüller. This prevents both forward and backward flow of tears and secretions, leading to accumulation within the lacrimal sac and progressive cystic enlargement. In some infants, an associated intranasal cyst may develop, further worsening obstruction and potentially causing nasal airway compromise.
Clinically, dacryocele presents as a firm, bluish swelling below the medial canthus in a neonate. The mass is typically non-mobile and may cause upward displacement of the lower eyelid. It may occur on one or both sides. In uncomplicated cases, it is painless, but secondary infection can lead to redness, tenderness, and swelling, indicating dacryocystitis or preseptal cellulitis. In severe cases, particularly when an intranasal cyst is present, the infant may develop respiratory distress, as newborns are obligate nasal breathers. Feeding difficulties may also be observed.
Diagnosis is primarily clinical, based on the characteristic appearance. Gentle pressure over the swelling may produce mucoid discharge from the puncta or into the nasal cavity, which supports the diagnosis. If infection is suspected, laboratory investigations such as complete blood count and cultures may be necessary. Imaging studies like CT or MRI are reserved for cases with suspected nasal obstruction or to evaluate for an intranasal cyst, and ENT consultation may be required.
The differential diagnosis includes other medial canthal masses such as capillary hemangioma, dermoid cyst, and encephalocele. These can usually be distinguished based on their clinical features, including color, consistency, mobility, and location.
Initial management often involves conservative treatment with gentle digital massage, which may decompress the cyst. If infection is present, systemic antibiotics are required due to the risk of serious complications. However, many cases, especially those with infection or airway compromise, require surgical intervention. The definitive treatment is probing and irrigation of the nasolacrimal duct, often performed under general anesthesia. Nasal endoscopy may be used to identify and treat associated intranasal cysts, improving success rates.
The prognosis is excellent, with approximately 99% resolution following appropriate surgical management, particularly when nasal endoscopy is utilized. Nevertheless, some infants may later develop typical nasolacrimal duct obstruction.
Complications, although uncommon, include recurrent obstruction, fistula formation if improperly drained externally, and infections such as dacryocystitis, preseptal cellulitis, or even sepsis and meningitis. Parents should be educated on proper massage techniques and advised to watch for warning signs such as redness, swelling, fever, or breathing and feeding difficulties, which require urgent medical evaluation.
- Published on
Ophthalmology – Cystoid Macular Edema (CME)
Cystoid macular edema (CME) is a condition characterized by accumulation of fluid within the retinal layers of the macula, particularly in the perifoveal region, leading to blurred or decreased central vision. It represents a final common pathway of many ocular diseases rather than a single disease entity. The most common form is postoperative CME, especially following cataract surgery.
CME occurs due to breakdown of the blood-retinal barrier, resulting in leakage of fluid into the retinal tissue. Although the exact mechanism is not fully understood, contributing factors include inflammation, vitreous traction, and vascular instability. Fluid accumulates either intracellularly (within Müller cells) or extracellularly, forming characteristic cystic spaces.
Clinically, CME may be asymptomatic or present with blurred vision, decreased visual acuity, or metamorphopsia (distorted vision). It is especially important to ask about recent ocular surgery, as well as systemic conditions such as diabetes, uveitis, or hypertension, and medications like prostaglandin analogs or niacin, which may contribute to its development.
On examination, findings include foveal thickening and cystic changes in the macula. However, mild cases may not be easily visible clinically and require imaging. Optical coherence tomography (OCT) is the most sensitive tool, showing increased retinal thickness and cystic spaces, often in the outer plexiform layer, sometimes with subretinal fluid. Fluorescein angiography (FA) classically demonstrates a “petaloid” pattern of dye leakage in the macula along with optic disc hyperfluorescence.
CME has numerous causes, including:
If CME persists, second-line treatments include periocular or intravitreal corticosteroid injections and intravitreal anti-VEGF agents (e.g., bevacizumab). Additional therapies such as oral acetazolamide may be helpful in select cases. In cases related to structural causes like vitreomacular traction or epiretinal membrane, vitrectomy surgery may be required.
Patients should be monitored every 4–6 weeks with OCT to assess response to treatment. Prognosis is generally good for postoperative CME, especially with early detection and appropriate management. However, chronic or untreated CME can lead to permanent vision loss due to macular damage.
Cystoid macular edema (CME) is a condition characterized by accumulation of fluid within the retinal layers of the macula, particularly in the perifoveal region, leading to blurred or decreased central vision. It represents a final common pathway of many ocular diseases rather than a single disease entity. The most common form is postoperative CME, especially following cataract surgery.
CME occurs due to breakdown of the blood-retinal barrier, resulting in leakage of fluid into the retinal tissue. Although the exact mechanism is not fully understood, contributing factors include inflammation, vitreous traction, and vascular instability. Fluid accumulates either intracellularly (within Müller cells) or extracellularly, forming characteristic cystic spaces.
Clinically, CME may be asymptomatic or present with blurred vision, decreased visual acuity, or metamorphopsia (distorted vision). It is especially important to ask about recent ocular surgery, as well as systemic conditions such as diabetes, uveitis, or hypertension, and medications like prostaglandin analogs or niacin, which may contribute to its development.
On examination, findings include foveal thickening and cystic changes in the macula. However, mild cases may not be easily visible clinically and require imaging. Optical coherence tomography (OCT) is the most sensitive tool, showing increased retinal thickness and cystic spaces, often in the outer plexiform layer, sometimes with subretinal fluid. Fluorescein angiography (FA) classically demonstrates a “petaloid” pattern of dye leakage in the macula along with optic disc hyperfluorescence.
CME has numerous causes, including:
- Post-surgical (most common) – especially after cataract surgery
- Diabetic retinopathy
- Retinal vein occlusion
- Uveitis and retinal vasculitis
- Age-related macular degeneration
- Vitreomacular traction or epiretinal membrane
- Drug-induced (e.g., prostaglandins, tamoxifen)
If CME persists, second-line treatments include periocular or intravitreal corticosteroid injections and intravitreal anti-VEGF agents (e.g., bevacizumab). Additional therapies such as oral acetazolamide may be helpful in select cases. In cases related to structural causes like vitreomacular traction or epiretinal membrane, vitrectomy surgery may be required.
Patients should be monitored every 4–6 weeks with OCT to assess response to treatment. Prognosis is generally good for postoperative CME, especially with early detection and appropriate management. However, chronic or untreated CME can lead to permanent vision loss due to macular damage.
- Published on
41. Ophthalmology – Crouzon Syndrome
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
- Published on
Ophthalmology – Craniosynostoses
Craniosynostoses are a group of craniofacial disorders characterized by premature fusion of one or more cranial sutures, leading to abnormal skull growth (craniostenosis). They are broadly classified into simple craniosynostosis (single suture involvement) and compound craniosynostosis (multiple sutures). These may occur as primary (genetic) conditions or secondary to other systemic disorders.
The condition is most commonly genetic, with several well-known syndromic associations. Crouzon syndrome is the most common craniosynostosis syndrome, followed by Apert syndrome, Pfeiffer syndrome, and Saethre–Chotzen syndrome. These are typically inherited in an autosomal dominant pattern and often involve mutations in fibroblast growth factor receptor genes (FGFR2, FGFR3, FGFR1) or transcription factors like TWIST1. Advanced paternal or maternal age is associated with new mutations in some syndromes.
Pathophysiologically, premature closure of a cranial suture restricts skull growth perpendicular to that suture while allowing compensatory growth parallel to it (Virchow’s law). This results in characteristic cranial deformities and may lead to increased intracranial pressure, abnormal brain development, and orbital abnormalities.
Ophthalmic involvement is common and clinically significant. Up to 90% of vision loss is due to amblyopia, while the remainder is related to structural abnormalities. Patients may exhibit proptosis (exorbitism) due to shallow orbits, leading to corneal exposure and risk of keratopathy. Other findings include strabismus (often exotropia), refractive errors, telecanthus, hypertelorism, nasolacrimal duct obstruction, and optic nerve abnormalities such as papilledema or compression. Eyelid abnormalities such as ptosis, coloboma, entropion, or ectropion may also be present.
Diagnosis involves a combination of clinical examination, family history, and genetic testing. Imaging plays a key role, particularly CT scans with 3D reconstruction to evaluate suture fusion and craniofacial anatomy, along with MRI when intracranial structures need assessment. Evaluation is multidisciplinary, involving ophthalmology, neurosurgery, genetics, and craniofacial teams.
Management is complex and requires a multidisciplinary approach. Early intervention focuses on relieving intracranial pressure and allowing normal brain growth, often via cranial vault surgery. Later procedures aim to correct orbital position and facial structure. Ophthalmologic care is essential for managing amblyopia, strabismus, exposure keratopathy, and optic nerve monitoring. Surgical interventions such as tarsorrhaphy, eyelid reconstruction, or strabismus surgery may be required.
Long-term follow-up is critical. Patients must be monitored for visual development, corneal exposure, optic nerve changes (papilledema), and ocular alignment issues. With timely and coordinated care, many complications—especially visual loss—can be minimized, although outcomes depend on the severity of the syndrome and associated abnormalities.
Craniosynostoses are a group of craniofacial disorders characterized by premature fusion of one or more cranial sutures, leading to abnormal skull growth (craniostenosis). They are broadly classified into simple craniosynostosis (single suture involvement) and compound craniosynostosis (multiple sutures). These may occur as primary (genetic) conditions or secondary to other systemic disorders.
The condition is most commonly genetic, with several well-known syndromic associations. Crouzon syndrome is the most common craniosynostosis syndrome, followed by Apert syndrome, Pfeiffer syndrome, and Saethre–Chotzen syndrome. These are typically inherited in an autosomal dominant pattern and often involve mutations in fibroblast growth factor receptor genes (FGFR2, FGFR3, FGFR1) or transcription factors like TWIST1. Advanced paternal or maternal age is associated with new mutations in some syndromes.
Pathophysiologically, premature closure of a cranial suture restricts skull growth perpendicular to that suture while allowing compensatory growth parallel to it (Virchow’s law). This results in characteristic cranial deformities and may lead to increased intracranial pressure, abnormal brain development, and orbital abnormalities.
Ophthalmic involvement is common and clinically significant. Up to 90% of vision loss is due to amblyopia, while the remainder is related to structural abnormalities. Patients may exhibit proptosis (exorbitism) due to shallow orbits, leading to corneal exposure and risk of keratopathy. Other findings include strabismus (often exotropia), refractive errors, telecanthus, hypertelorism, nasolacrimal duct obstruction, and optic nerve abnormalities such as papilledema or compression. Eyelid abnormalities such as ptosis, coloboma, entropion, or ectropion may also be present.
Diagnosis involves a combination of clinical examination, family history, and genetic testing. Imaging plays a key role, particularly CT scans with 3D reconstruction to evaluate suture fusion and craniofacial anatomy, along with MRI when intracranial structures need assessment. Evaluation is multidisciplinary, involving ophthalmology, neurosurgery, genetics, and craniofacial teams.
Management is complex and requires a multidisciplinary approach. Early intervention focuses on relieving intracranial pressure and allowing normal brain growth, often via cranial vault surgery. Later procedures aim to correct orbital position and facial structure. Ophthalmologic care is essential for managing amblyopia, strabismus, exposure keratopathy, and optic nerve monitoring. Surgical interventions such as tarsorrhaphy, eyelid reconstruction, or strabismus surgery may be required.
Long-term follow-up is critical. Patients must be monitored for visual development, corneal exposure, optic nerve changes (papilledema), and ocular alignment issues. With timely and coordinated care, many complications—especially visual loss—can be minimized, although outcomes depend on the severity of the syndrome and associated abnormalities.
- Published on
Ophthalmology – Crystalline Keratopathy
Crystalline keratopathy refers to a group of corneal disorders characterized by crystal-like deposits or branching opacities within the cornea. It is broadly divided into two categories: infectious crystalline keratopathy (ICK) and deposition-related keratopathy. In clinical practice, the term most commonly refers to the infectious form, which is a distinctive, indolent corneal infection marked by minimal inflammation despite microbial presence.
Infectious crystalline keratopathy is an uncommon condition, often associated with corneal grafts, chronic topical steroid use, refractive surgery, contact lens wear, prior herpes simplex keratitis, and systemic immunosuppression. The pathogenesis involves microorganisms colonizing the interlamellar spaces of the corneal stroma, where they produce a biofilm and extracellular matrix. This biofilm shields the organisms from host immune responses and antibiotics, explaining the characteristically minimal inflammatory reaction despite active infection.
The most commonly implicated organisms include Streptococcus viridans, Candida species, and nontuberculous mycobacteria, although infections may be polymicrobial. Patients typically present with gradual visual decline or an incidental finding of a corneal opacity, rather than acute pain or redness.
On examination, the hallmark finding is a white, branching, needle-like crystalline opacity within the anterior corneal stroma, often described as “snowflake” or “tree-like.” Notably, there is little to no surrounding inflammation, which helps distinguish it from typical infectious keratitis. The lesion tends to expand slowly, and anterior chamber reaction is usually absent unless the infection is deeper or more advanced.
Diagnosis relies on corneal scraping or biopsy for culture and sensitivity, although organisms can be difficult to grow due to special nutrient requirements. Additional tools such as corneal optical coherence tomography, confocal microscopy, and PCR testing may aid in detection. In cases where deposition is suspected instead of infection, systemic evaluation (e.g., lipid profile, protein electrophoresis) may be necessary to rule out metabolic or hematologic causes.
Management is often prolonged and challenging. Treatment is organism-specific, typically starting with broad-spectrum topical antibiotics such as fluoroquinolones, then tailored based on culture results. Gram-positive infections may require cefazolin or vancomycin, while gram-negative coverage includes tobramycin or gentamicin. Fungal cases are treated with amphotericin B or voriconazole. Importantly, topical steroids should be reduced or discontinued if possible, as they contribute to disease persistence.
In refractory cases, additional interventions such as Nd:YAG laser disruption of crystals, surgical debridement, or even lamellar or penetrating keratoplasty may be required. Long-term follow-up is essential due to the risk of recurrence or graft failure, particularly in post-transplant patients.
The prognosis is guarded, as the condition is often chronic and resistant to treatment. Complications include persistent infection, corneal scarring, and graft rejection, all of which can significantly impact visual outcomes.
Crystalline keratopathy refers to a group of corneal disorders characterized by crystal-like deposits or branching opacities within the cornea. It is broadly divided into two categories: infectious crystalline keratopathy (ICK) and deposition-related keratopathy. In clinical practice, the term most commonly refers to the infectious form, which is a distinctive, indolent corneal infection marked by minimal inflammation despite microbial presence.
Infectious crystalline keratopathy is an uncommon condition, often associated with corneal grafts, chronic topical steroid use, refractive surgery, contact lens wear, prior herpes simplex keratitis, and systemic immunosuppression. The pathogenesis involves microorganisms colonizing the interlamellar spaces of the corneal stroma, where they produce a biofilm and extracellular matrix. This biofilm shields the organisms from host immune responses and antibiotics, explaining the characteristically minimal inflammatory reaction despite active infection.
The most commonly implicated organisms include Streptococcus viridans, Candida species, and nontuberculous mycobacteria, although infections may be polymicrobial. Patients typically present with gradual visual decline or an incidental finding of a corneal opacity, rather than acute pain or redness.
On examination, the hallmark finding is a white, branching, needle-like crystalline opacity within the anterior corneal stroma, often described as “snowflake” or “tree-like.” Notably, there is little to no surrounding inflammation, which helps distinguish it from typical infectious keratitis. The lesion tends to expand slowly, and anterior chamber reaction is usually absent unless the infection is deeper or more advanced.
Diagnosis relies on corneal scraping or biopsy for culture and sensitivity, although organisms can be difficult to grow due to special nutrient requirements. Additional tools such as corneal optical coherence tomography, confocal microscopy, and PCR testing may aid in detection. In cases where deposition is suspected instead of infection, systemic evaluation (e.g., lipid profile, protein electrophoresis) may be necessary to rule out metabolic or hematologic causes.
Management is often prolonged and challenging. Treatment is organism-specific, typically starting with broad-spectrum topical antibiotics such as fluoroquinolones, then tailored based on culture results. Gram-positive infections may require cefazolin or vancomycin, while gram-negative coverage includes tobramycin or gentamicin. Fungal cases are treated with amphotericin B or voriconazole. Importantly, topical steroids should be reduced or discontinued if possible, as they contribute to disease persistence.
In refractory cases, additional interventions such as Nd:YAG laser disruption of crystals, surgical debridement, or even lamellar or penetrating keratoplasty may be required. Long-term follow-up is essential due to the risk of recurrence or graft failure, particularly in post-transplant patients.
The prognosis is guarded, as the condition is often chronic and resistant to treatment. Complications include persistent infection, corneal scarring, and graft rejection, all of which can significantly impact visual outcomes.
- Published on
Ophthalmology – Diabetic Papillopathy
Diabetic papillopathy is an uncommon, typically benign optic disc swelling seen in patients with diabetes mellitus. It may occur unilaterally or bilaterally and is characterized by transient optic disc edema that usually resolves spontaneously over several months. Importantly, optic nerve dysfunction is generally mild, and visual prognosis is good. A key clinical challenge is distinguishing this condition from neovascularization of the disc in proliferative diabetic retinopathy, which carries more serious implications.
This condition can occur in diabetics of any age, although it is more frequently reported in younger patients. Both males and females are equally affected. The main risk factors include poor glycemic control and long-standing diabetes, highlighting the importance of metabolic regulation in prevention.
The exact pathophysiology remains uncertain, but it is thought to involve a microvascular abnormality of the superficial capillaries of the optic nerve head, leading to leakage and disc swelling. It is commonly associated with other diabetic eye conditions, particularly diabetic retinopathy and macular edema.
Patients typically present with a painless, mild decrease in vision, although visual acuity may remain normal in some cases. The most common visual field defect is an enlarged blind spot, and color vision is usually normal or only mildly affected. On examination, the optic disc appears hyperemic and swollen, often with dilated, radially oriented telangiectatic vessels. There is usually minimal or no afferent pupillary defect, which helps differentiate it from more severe optic neuropathies.
Diagnostic evaluation includes laboratory tests such as HbA1c, blood pressure, and other systemic investigations to exclude alternative causes of optic disc swelling. MRI of the brain and orbits is often performed to rule out compressive or demyelinating conditions. Fluorescein angiography (FA) is particularly useful, showing optic disc hyperfluorescence with leakage from telangiectatic vessels, but importantly without the vitreous leakage seen in neovascularization.
The differential diagnosis is broad and includes non-arteritic anterior ischemic optic neuropathy (NAION), papilledema, optic neuritis, hypertensive retinopathy, and proliferative diabetic retinopathy. Because of this, diabetic papillopathy is often considered a diagnosis of exclusion.
There is no specific treatment for diabetic papillopathy itself, as it is self-limiting. Management focuses on optimizing blood glucose control and monitoring for associated conditions such as diabetic retinopathy or macular edema, which may require laser photocoagulation or other retinal therapies.
Close follow-up is essential, typically every 2–3 weeks, to monitor resolution of disc edema and ensure that no alternative diagnosis emerges. Patients should be educated on the importance of strict glycemic control, as this plays a critical role in both prevention and overall ocular health.
The prognosis is generally excellent, with most patients experiencing resolution of disc swelling. However, some may have mild residual visual field defects, and visual morbidity may arise from associated diabetic macular edema rather than the papillopathy itself.
Diabetic papillopathy is an uncommon, typically benign optic disc swelling seen in patients with diabetes mellitus. It may occur unilaterally or bilaterally and is characterized by transient optic disc edema that usually resolves spontaneously over several months. Importantly, optic nerve dysfunction is generally mild, and visual prognosis is good. A key clinical challenge is distinguishing this condition from neovascularization of the disc in proliferative diabetic retinopathy, which carries more serious implications.
This condition can occur in diabetics of any age, although it is more frequently reported in younger patients. Both males and females are equally affected. The main risk factors include poor glycemic control and long-standing diabetes, highlighting the importance of metabolic regulation in prevention.
The exact pathophysiology remains uncertain, but it is thought to involve a microvascular abnormality of the superficial capillaries of the optic nerve head, leading to leakage and disc swelling. It is commonly associated with other diabetic eye conditions, particularly diabetic retinopathy and macular edema.
Patients typically present with a painless, mild decrease in vision, although visual acuity may remain normal in some cases. The most common visual field defect is an enlarged blind spot, and color vision is usually normal or only mildly affected. On examination, the optic disc appears hyperemic and swollen, often with dilated, radially oriented telangiectatic vessels. There is usually minimal or no afferent pupillary defect, which helps differentiate it from more severe optic neuropathies.
Diagnostic evaluation includes laboratory tests such as HbA1c, blood pressure, and other systemic investigations to exclude alternative causes of optic disc swelling. MRI of the brain and orbits is often performed to rule out compressive or demyelinating conditions. Fluorescein angiography (FA) is particularly useful, showing optic disc hyperfluorescence with leakage from telangiectatic vessels, but importantly without the vitreous leakage seen in neovascularization.
The differential diagnosis is broad and includes non-arteritic anterior ischemic optic neuropathy (NAION), papilledema, optic neuritis, hypertensive retinopathy, and proliferative diabetic retinopathy. Because of this, diabetic papillopathy is often considered a diagnosis of exclusion.
There is no specific treatment for diabetic papillopathy itself, as it is self-limiting. Management focuses on optimizing blood glucose control and monitoring for associated conditions such as diabetic retinopathy or macular edema, which may require laser photocoagulation or other retinal therapies.
Close follow-up is essential, typically every 2–3 weeks, to monitor resolution of disc edema and ensure that no alternative diagnosis emerges. Patients should be educated on the importance of strict glycemic control, as this plays a critical role in both prevention and overall ocular health.
The prognosis is generally excellent, with most patients experiencing resolution of disc swelling. However, some may have mild residual visual field defects, and visual morbidity may arise from associated diabetic macular edema rather than the papillopathy itself.
- Published on
Ophthalmology – Dissociated Strabismus
Dissociated strabismus refers to a unique type of ocular deviation in which refixation of one eye does not produce a corresponding opposite movement in the fellow eye, distinguishing it from true tropias. Because the deviation can involve vertical, horizontal, and torsional components, the broader and more accurate term is dissociated strabismus complex (DSC). The classic movement seen is a slow elevation, abduction, and extorsion of the non-fixing eye, often occurring intermittently.
DSC is commonly subdivided into three components: dissociated vertical deviation (DVD), dissociated horizontal deviation (DHD), and dissociated torsional deviation (DTD). These components may occur individually or in combination. The condition is typically comitant, meaning the deviation appears similar in all directions of gaze. DVD is the most recognized form and is found in a large proportion (45–92%) of patients with congenital or infantile esotropia.
Risk factors include early-onset strabismus (especially infantile esotropia), monofixation syndrome, latent or manifest-latent nystagmus, and amblyopia. These associations suggest that DSC is strongly linked to abnormal early binocular visual development. Although the exact pathophysiology is not fully understood, it is believed to involve abnormal supranuclear control of eye movements. One theory proposes that DVD represents a compensatory mechanism to dampen underlying nystagmus.
Clinically, parents often report that one eye drifts upward or outward intermittently, especially when the child is tired, ill, or daydreaming. The deviation may vary significantly over time. Importantly, diplopia is absent, and true bifoveal fixation is lacking. On examination, the non-fixing eye demonstrates the characteristic movement pattern of elevation, abduction, and extorsion.
Diagnosis relies heavily on clinical examination. The cover–uncover and alternate cover tests are essential. In contrast to a true hypertropia, refixation does not induce a corresponding downward movement in the fellow eye, which is a key distinguishing feature of DVD. The deviation can be graded in severity and may fluctuate between visits. Additional tests such as Worth 4-dot, Bagolini lenses, and stereoacuity testing help evaluate binocular function and identify associated monofixation.
The differential diagnosis includes inferior oblique overaction, true hypertropia, exotropia, and cyclotorsional abnormalities. DSC can mimic these conditions, particularly inferior oblique overaction, making careful examination essential.
Management focuses first on optimizing visual development, including correction of refractive errors and treatment of amblyopia. There is no definitive cure for dissociated strabismus. Surgical intervention may be considered for cosmetically significant or poorly controlled deviations. Procedures include large recessions of the superior rectus muscle, inferior oblique anterior transposition, or lateral rectus recession for horizontal components. However, outcomes are variable, and recurrence is common.
Long-term follow-up is important to monitor for amblyopia, progression or recurrence of deviation, and the presence of associated strabismus. Families should be counseled that while treatment can improve alignment and appearance, complete resolution is rarely achievable, and the condition often persists to some degree.
Dissociated strabismus refers to a unique type of ocular deviation in which refixation of one eye does not produce a corresponding opposite movement in the fellow eye, distinguishing it from true tropias. Because the deviation can involve vertical, horizontal, and torsional components, the broader and more accurate term is dissociated strabismus complex (DSC). The classic movement seen is a slow elevation, abduction, and extorsion of the non-fixing eye, often occurring intermittently.
DSC is commonly subdivided into three components: dissociated vertical deviation (DVD), dissociated horizontal deviation (DHD), and dissociated torsional deviation (DTD). These components may occur individually or in combination. The condition is typically comitant, meaning the deviation appears similar in all directions of gaze. DVD is the most recognized form and is found in a large proportion (45–92%) of patients with congenital or infantile esotropia.
Risk factors include early-onset strabismus (especially infantile esotropia), monofixation syndrome, latent or manifest-latent nystagmus, and amblyopia. These associations suggest that DSC is strongly linked to abnormal early binocular visual development. Although the exact pathophysiology is not fully understood, it is believed to involve abnormal supranuclear control of eye movements. One theory proposes that DVD represents a compensatory mechanism to dampen underlying nystagmus.
Clinically, parents often report that one eye drifts upward or outward intermittently, especially when the child is tired, ill, or daydreaming. The deviation may vary significantly over time. Importantly, diplopia is absent, and true bifoveal fixation is lacking. On examination, the non-fixing eye demonstrates the characteristic movement pattern of elevation, abduction, and extorsion.
Diagnosis relies heavily on clinical examination. The cover–uncover and alternate cover tests are essential. In contrast to a true hypertropia, refixation does not induce a corresponding downward movement in the fellow eye, which is a key distinguishing feature of DVD. The deviation can be graded in severity and may fluctuate between visits. Additional tests such as Worth 4-dot, Bagolini lenses, and stereoacuity testing help evaluate binocular function and identify associated monofixation.
The differential diagnosis includes inferior oblique overaction, true hypertropia, exotropia, and cyclotorsional abnormalities. DSC can mimic these conditions, particularly inferior oblique overaction, making careful examination essential.
Management focuses first on optimizing visual development, including correction of refractive errors and treatment of amblyopia. There is no definitive cure for dissociated strabismus. Surgical intervention may be considered for cosmetically significant or poorly controlled deviations. Procedures include large recessions of the superior rectus muscle, inferior oblique anterior transposition, or lateral rectus recession for horizontal components. However, outcomes are variable, and recurrence is common.
Long-term follow-up is important to monitor for amblyopia, progression or recurrence of deviation, and the presence of associated strabismus. Families should be counseled that while treatment can improve alignment and appearance, complete resolution is rarely achievable, and the condition often persists to some degree.
